Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oculis Holding AG Ordinary shares
OCSCurrent price
14.71 USD
-0.19 USD (-1.28%)
Last closed
14.72 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
679 613 504 USD
Yield for 12 month
+49.95 %
1Y
3Y
5Y
10Y
15Y
OCS
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. The company is based in Zug, Switzerland. Address: Bahnhofstrasse 7, Zug, Switzerland, 6300
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
28.75 USDP/E ratio
–Dividend Yield
–Current Year
+1 002 646 USD
Last Year
+1 035 575 USD
Current Quarter
+278 197 USD
Last Quarter
+252 081 USD
Current Year
-32 207 297 USD
Last Year
-24 199 757 USD
Current Quarter
-18 417 796 USD
Last Quarter
-12 074 898 USD
Key Figures OCS
1 year
3 years
5 years
10 years
EBITDA
-62 840 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.77 %
PEG Ratio
–
Return On Equity TTM
-58.12 %
Wall Street Target Price
28.75 USD
Revenue TTM
871 000 USD
Book Value
2.56 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-2 %
Dividend Yield
–
Gross Profit TTM
-21 312 000 USD
Earnings per share
-1.6 USD
Diluted Eps TTM
-1.6 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OCS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OCS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation OCS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
780.2681
Enterprise Value EBITDA
-3.4743
Price Book MRQ
5.2754
Financials OCS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OCS
For 52 weeks
9.6 USD
18 USD
50 Day MA
14.01 USD
Shares Short Prior Month
19 246
200 Day MA
12.46 USD
Short Ratio
1.01
Shares Short
45 139
Short Percent
0.14 %
BeatStart